News
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...
China's Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental weight-loss drug for ...
Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...
Rhythm Pharmaceuticals develops medicines for rare disorders that cause weight gain. The company's only approved product is ...
1d
GlobalData on MSNNovo Nordisk defeated in Wegovy patent dispute by Viatris
The Delaware court ruled that Viatris’ drug does not infringe the "administered without another therapeutic agent" limitation ...
GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...
We can't have it both ways. If we want more cutting-edge drugs, we have to protect the property rights that make them ...
After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead. Yet another ...
More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...
A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...
Ongoing patent battle between Novo Nordisk and Dr Reddy’s Laboratories over semaglutide export to multiple countries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results